Cyrano Therapeutics is developing an intranasal product designed to restore function in patients with a chronic loss of taste and smell
Cyrano Therapeutics is developing an intranasal product designed to restore function in patients with a chronic loss of taste and smell. The company's product (CYR-001) repurposes an approved molecule (Theophylline) for this new indication and has been tested with success in a pilot study.